Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol
Open Access
- 20 July 2021
- Vol. 10 (7), 911
- https://doi.org/10.3390/pathogens10070911
Abstract
Background: The protocol study will focus on the seroprevalence of IgG antibodies to SARS-CoV-2 achieved by vaccination and/or natural protection as well as the history, symptoms, and risk factors for SARS-CoV-2 in four primary health-care workers (PHCWs) and their household contacts in metropolitan France. Methods: Here, we propose a protocol for a nationwide survey to determine the seroprevalence of IgG antibodies to SARS-CoV-2 achieved by vaccination and/or natural protection in four PHCW populations (general practitioners, pediatricians, pharmacists and assistants, and dentists and assistants) and their household contacts. Participants will be included from June to July 2021 (Phase 1) among PHCW populations located throughout metropolitan France. They will be asked to provide a range of demographic and behavioral information since the first SARS-CoV-2 wave and a self-sampled dried blood spot. Phase 1 will involve also a questionnaire and serological study of PHCWs’ household contacts. Seroprevalence will be estimated using two ELISAs designed to detect specific IgG antibodies to SARS-CoV-2 in humoral fluid, and these results will be confirmed using a virus neutralization test. This study will be repeated from November to December 2021 (Phase 2) to evaluate the evolution of immune status achieved by vaccination and/or natural protection of PHCWs and to describe the history of exposure to SARS-CoV-2.Funding Information
- Agence Nationale de la Recherche (ANR-20-COV5-0005-01)
This publication has 21 references indexed in Scilit:
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesThe New England Journal of Medicine, 2020
- Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020Journal of Clinical Medicine, 2020
- Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donorsAntiviral Research, 2020
- Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalNature Communications, 2020
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet, 2020
- Characteristics of Health Care Personnel with COVID-19 — United States, February 12–April 9, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Beyond the assistance: additional exposure situations to COVID-19 for healthcare workersJournal of Hospital Infection, 2020
- Seroprevalence of SARS-CoV-2 Among Adults in Three Regions of France Following the Lockdown and Associated Risk Factors: A Multicohort StudySSRN Electronic Journal, 2020
- THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIALBiometrika, 1934